17th Annual World Preclinical Congress – Boston, MA (18th-21st June)

Dr Colin Brown will be attending the 17th Annual World Preclinical Congress between 18th and 21st June in Boston.

Dr Brown is the developer of the aProximateTM assay for measuring kidney transporter and nephrotoxicity licensed exclusively to Newcells Biotech.

The World Preclinical Congress is a key networking event focusing on the latest trends and technologies impacting drug discovery and translational research.

Dr Brown will be meeting with partners with research interests in renal, hepatic and GI drug transporters. If you are attending the World Preclinical Congress and would like to arrange a meeting with Dr Brown, then please let us know – https://newcellsbiotech.co.uk/collaborate/ 

 

You might also be interested in…
retinal pigmented epithelium (RPE)
Blog

Newcells Biotech Ltd. RPE Model to Improve Drug Retinal Toxicity Assessment

Retinal toxicity is an adverse side effect that can cause (usually irreversible) deterioration of a person’s vision, when taking certain medication. This has been seen for example in people taking Hydroxychloroquine for Malaria due to toxicity to the retinal cells.  The retinal pigmented epithelium (RPE) is